0001209191-22-062662.txt : 20221223
0001209191-22-062662.hdr.sgml : 20221223
20221223173217
ACCESSION NUMBER: 0001209191-22-062662
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221222
FILED AS OF DATE: 20221223
DATE AS OF CHANGE: 20221223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Zelen Matt
CENTRAL INDEX KEY: 0001887917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41049
FILM NUMBER: 221486230
MAIL ADDRESS:
STREET 1: C/O USERTESTING, INC.
STREET 2: 144 TOWNSEND STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UserTesting, Inc.
CENTRAL INDEX KEY: 0001557127
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 260339214
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 144 TOWNSEND STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
BUSINESS PHONE: (650) 567-5616
MAIL ADDRESS:
STREET 1: 144 TOWNSEND STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
FORMER COMPANY:
FORMER CONFORMED NAME: User Testing, Inc.
DATE OF NAME CHANGE: 20120828
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-22
0
0001557127
UserTesting, Inc.
USER
0001887917
Zelen Matt
144 TOWNSEND STREET
SAN FRANCISCO
CA
94107
0
1
0
0
Chief Operating Officer
Common Stock
2022-12-22
4
M
0
13750
1.06
A
39932
D
Common Stock
2022-12-22
4
S
0
19046
7.5007
D
20886
D
Employee Stock Option (Right to Buy)
1.06
2022-12-22
4
M
0
13750
0.00
D
2029-12-23
Common Stock
13750
708750
D
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.50 to $7.505 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option vested as to 1/4th of the total shares December 2, 2020 and then 1/48th of the total shares vest monthly thereafter, subject to the Reporting Holder's continued service to the Issuer on each vesting date.
/s/ Mona Sabet as attorney-in-fact for Matt Zelen
2022-12-23